throbber
mykosen 19 (7) 251--256
`~) Grosse Verlag 1976
`
`Eingegangen am 29. September 1975
`
`Miconazole alcoholic solution in the treatment
`of mycotic nail infections
`
`J. VANDERDONCKT, W. LAUWERS and J. BOCKAERT
`
`Summary
`
`Nineteen men, suffering from dlronic onychomycosis of their toe nails, were treated for
`32 weeks with a 2 ~o miconazole alcoholic solution. Of 20 nails positive by culture before
`treatment, all were cured clinically and 15 showed no growth of pathogenic fungi six
`months after treatment. The medication was excellently tolerated.
`
`Zusammenfassung
`
`Neunzehn m~nnliche Patienten, die mit daronischer Onychomykose der Zehenn~igel
`befallen waren, wurden wiihrend 32 Wochen mit einer 2 ~o Miconazole enthaltenden
`AlkohollSsung behandelt. Von den 20 mykologisch positiv gesicherten N~igeln haben sich
`alle nach Behandlung als klinisch geheilt erwiesen, und bei 15 yon ihnen wurden 6 Monate
`nach Behandlung keine pathogenen Pilze nachgewiesen. Die Miconazol-Lfsung wurde aus-
`gezdchnet vertragen.
`
`In recent years, several new drugs have been introduced for the treatment of onycho-
`mycosis, by either local or systemic routes. Results have often been disappointing.
`In 1971, however, BOTTER (1) reported extremely good results in the treatment of
`onychomycosis with miconazole 2 ~o cream. The drug was applied under occlusive ban-
`dages and, in some instances, combined with griseofulvin therapy. HEmKE confirmed
`these findings (2).
`Miconazole is a synthetic compound, produced in the laboratories of Janssen Pharma-
`ceutica. It has proved to be active against most fungi, including dermatophytes and yeasts,
`and against gram-positive bacteria, both in vitro (3) and in vivo (1, 4, 5, 6).
`When the drug became available as a film forming alcoholic solution,* the advantages
`of th.is formulation over the cream for the treatment of onychomycosis were obvious, i. e.
`easy application of the drug and inconspicuousness of the treatment.
`In the present paper we report on the first clinical evaluation of 2 % miconazole alco-
`holic solution.
`
`* Formula: miconazole base
`carbosept No. 525
`carbosept No. 515
`propylene glycol U. S.P.
`ethanol U. S. P. ad
`
`0.2 gram
`0,475 gram
`0.025 gram
`gram
`2
`ml
`10
`
`Key words: Miconazole a!coholic solution, onychomycosis, dermatophytes, yeasts.
`
`ACRUX DDS PTY LTD. et al.
`EXHIBIT 1035
`IPR Petition for
`U.S. Patent No. 7,214,506
`
`1 of 6
`
`

`
`252
`
`J. VANDERDONCKT, W. LAUW~RS and J. BOCKAERT
`
`Table 1: Individual case data; causative fungi and severity of lesions before treatment
`
`Patient
`No.
`
`Age
`
`Left food
`
`Fungus
`
`Fungal etiology
`
`Right food
`
`Severity
`of lesion
`
`Fungus
`
`Severity
`of lesion
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`
`67
`68
`78
`36
`69
`42
`69
`65
`65
`53
`67
`43
`44
`37
`49
`37
`43
`47
`30
`
`Trichophyton mentagrophytes + + +
`+ + +
`T. mentagrophytes
`+ + +
`T. rubrum
`+ + +
`T. mentagrophytes
`+ +
`T. mentagrophytes
`negative
`+ + +
`+ +
`T. mentagrophytes
`+ + +
`T. rubrum
`+ + +
`negative
`positive
`+ + +
`+ +
`positive
`+ + +
`T. mentagrophytes
`negative
`+ + +
`Candida troplcalis
`+ +
`+ + +
`negative
`--::"
`+ +
`Scopulariopsis brevicz~ulis
`+ +
`+ +
`negative
`+ +
`negative
`
`negative
`+ + +
`0
`--**
`+ + +
`negative
`Trichosporon cutanet~m + + +
`T. mentagrophytes
`+ +
`T. mentagrophytes
`+ + +
`T. mentagrophytes
`+ +
`+ +
`T. rubrum
`T. rubrum
`+ + +
`T. mentagrophytcs
`+ +
`+
`T. mentagrophytcs
`T. mentagrophytcs
`+ + +
`negative
`+ + +
`negative
`+ +
`negative
`+ +
`--*
`+ +
`+ +
`S. brevicaulis
`--**
`0
`--**
`0
`
`*: no mycological examination
`"*: normal nail
`
`O: not affected
`+ : light
`+ + : moderate
`+++: severe
`
`Material and methods
`
`Patient selection: Nineteen male long-term in-patients, were selected for the trial
`(median age: 49 years; range: 30--78 years) (Table 1). All of them presented with clinical
`signs of onychomycosis of at least the big-toe nails. These included subungual keratosis,
`discoloration, onycholysis, brittleness of the nails and, in some, paronychial inflammation.
`The duration of the infections ranged from 2 to 20 years. None of the patients had
`received antifungal treatment during the last two years.
`Assessments and identification of the etiologic fungi: Several patients had more than
`one infected nail. The nails were clinically scored with regard to the severity of the lesions
`(Table 2). Samples of the affected nails were taken and examined microcopically after
`potassium hydroxide clearing. Cultures were grown on Sabouraud P.S. and Sabouraud
`P. S. A. media. Identification of fungi was possible for 20 n~ils from 14 of the patients.
`Twelve infections were by Tricbopbyton mentagropbytes, 4 by T. rubrum, 2 by Scopu-
`lariopsis brevicaulis, 1 by Candida tropicalis and 1 by Tricbosporon cutaneum. Two nails
`positive on microscopical examanation, did not yield pathogenic fungi when cultured.
`Thirteen other nails presented a clinical picture of onychomycosis, but microscopic and
`cultural investigations were negative. One patient was not present at the time when
`samples for mycological procedures were taken.
`
`mykosen 19, Heft 7 (1976)
`
`2 of 6
`
`

`
`Miconazole alcoholic solution in the treatment of mycotic nail infections
`
`253
`
`Table z: Clinical evaluation of healing process during treatment period
`
`Pat. Nail
`No.
`
`4 w
`
`8w
`
`12 w 16 w 20 w Z8 w 32 w
`
`0
`0
`/ ,
`
`0
`0
`
`/
`
`I
`II
`II M
`I1
`I/
`
`II lit
`II III
`It
`lit
`
`o
`o
`
`I
`I
`I
`I
`
`o
`!
`
`e~
`
`ee
`
`/
`0
`
`o
`/
`
`!
`!
`o
`o
`/
`/
`o
`f
`0
`o
`
`0
`
`o
`e
`
`II
`M
`l/
`/
`II
`M
`I
`I
`/I
`I1
`o
`I
`
`M
`M
`
`M
`M
`o
`o
`
`o
`M
`0
`0
`
`f,
`
`/
`
`6
`
`M
`
`e
`
`o(cid:128)
`
`¢o
`
`MI MI
`MI
`let
`Ill
`tl1
`M/
`///
`
`ItM/
`/;1
`M/ MI
`III
`M/
`
`II/
`MI
`III
`IM
`II/
`//!
`M/ M/
`/M
`IM
`//t
`I//
`I1
`IM
`t
`M
`I//
`IM
`IM
`lit
`o
`I
`M M
`/
`M
`/
`M
`
`M
`
`o
`
`M!
`/ M
`
`I/ M
`
`# @
`
`3 7
`
`M IM
`M M/
`o
`M
`II M/
`
`II/
`MI
`I// MI
`f, , ’I’,,
`M/
`/1
`II
`IM
`MY IM
`MY MI
`7,
`’A
`II/ III
`M? IM
`"*
`II
`III ""
`" M/
`//// MY
`M/
`M IM
`Ill tit
`o
`
`!
`
`2
`
`3
`
`4
`
`s
`
`6
`
`7
`
`8
`
`9
`
`10
`
`II
`
`IZ
`
`13
`
`14
`
`15
`
`16
`
`L
`R
`
`L
`R
`L
`R
`
`L
`R
`L
`R
`L
`R
`
`h
`R
`
`L,
`R
`
`L
`R
`
`L
`R
`
`L
`R
`
`L
`R
`
`L
`R
`
`L
`
`K
`
`L
`R
`L
`g
`
`17 L
`R
`L
`R
`
`18
`
`0
`0
`
`0
`.P
`/
`0
`
`0
`0
`!
`!
`0
`0
`
`0
`0
`
`0
`0
`
`0
`0
`
`0
`0
`
`0
`0
`
`O
`0
`
`0
`0
`
`~e
`
`e*
`
`0
`0
`0
`0
`0
`0
`~o
`1o ~
`
`R ~
`
`o: not affected
`O@: absent
`
`Scoring of newly rown, clinically healthy nail
`O: no growth
`
`ifi growth up to 50~
`
`growth up to 75%
`practically complete or complege cure
`
`Treatment: Twice daily, 2 ~o miconazole alcoholic solution was applied to the affected
`toe nails using the drip-nozzle fitted to the bottles. The solution was allowed sufficient
`time to dry. Each time the previously applied miconazole film was removed. Special
`attention was paid to the application under the front edge of the nails along the lateral
`edges and the cuticles. The treatment lasted 32 weeks, during which time no other anti-
`fungal therapy was prescribed. Each patient was treated with his own bottle of micona-
`zole.
`The nursing staff of the hospital took special care of the hygienic measures taken during
`the trial. Feet were washed and socks were changed daily. Except for keeping the nails
`short, no special surgical treatment was applied.
`
`mykosen 19, Hef~ 7 (1976)
`
`3 of 6
`
`

`
`254
`
`J. VANDERDONCKT, W. LAUWERS and J. BOCKAERT
`
`Table 3: Individual results of mycological examination, 6 months after cessation of treatment
`
`Patient No.
`
`Left
`
`Fungal isolations
`
`1
`2
`3*
`4
`5
`6
`7
`8
`9
`10
`11
`12
`14
`16**
`17***
`
`negative
`negative
`--
`negative
`negative
`negative
`T. mentagrophytes
`T. mentagrophytes
`negative
`negative
`negative
`negative
`negative
`negative
`i
`
`Right
`
`negative
`negative
`
`negative
`negative
`negative
`T. mentagrophytes
`negative
`negative
`negative
`T. mentagrophytes
`negative
`negative
`T. rubrum
`I
`
`’:" Patient died before the control examination.
`** Not present at first examination.
`*** Not present at control examination.
`Patients 13, 15, 18 and 19 were negative before and after treatment.
`
`The aspect of the treated nails was evaluated monthly and the healing process was
`scored clinically. Six months after cessation of treatment a second mycological examina-
`tion (microscopic examination and culture) was performed to assess whether a permanent
`mycological cure had been obtained.
`
`Results
`
`Table 2 presents the individual clinical evaluation of the healing process and Figure 1
`the cumulative evaluation of all treated nails.
`After 16 weeks of treatment, more than 80 g of the treated nails showed a positive
`response to treatment. At the end of the 32-week treatment period, 80 g of the treated
`nails were virtually cured and in these cases a new and clinically healthy nail had devel-
`oped.
`During the entire treatment period the mlconazole alcoholic solution was well tolerated.
`No adverse local reactions occurred.
`Table 3 shows the results of the mycological examination six months after cessation
`of the treatment in 13 patients. Only 4 of the 17 nails that had been mycologically posi-
`tive before treatment yielded a pathogenic fungus. In three nails T. rnentagrophytes was
`still present. In one nail this fungus was also isolated; although before treatment T. ru-
`bruin had been recovered. Control samples could not be obtained from two patients
`(No. 3; No. 17). One patient had not been examined before treatment (No. 16). However
`after treatment T. rubrum was isolated from one nail while in another the microscopic
`examination was positive but no fungus could be cultured. Clinically, these 4 infected
`nails showed a picture of developing onychomycosis.
`
`mykosen 19, Heft 7 (1976)
`
`4 of 6
`
`

`
`Miconazole alcoholic solution in the treatment of mycotic nail infections
`
`255
`
`~0-
`
`30-
`
`20-
`
`Fig. 1: Cumulative evaluation of
`nail treatment: all treated nails
`
`I/~: SrOWt~ up to 75’7.
`/~i(cid:128)~: practically complete or complete cure
`
`O: no change
`
`Glinical evaluation
`
`Comments
`
`Clinical experience with miconazole in the treatment of onychomycosis is still limited.
`Our present study with a 2 g miconazole alcoholic solution appears to substantiate the
`results obtained with 2 g miconazole cream by BOTTER and HEmKE (1, 2).
`
`The main advantages of the miconazole solution are its broad spectrum of efficacy
`against fungi, including yeasts; ease of applicability and the absence of local irritation or
`allergic manifestations.
`It seems that, in long-standing and rooted onychomycoses, such as the cases treated here,
`miconazole solution is a convenient alternative to treatment with griseofulvin. The
`duration of treatment appears to be equal but, clearly, a topical application is to be
`preferred for the treatment of a localized disease such as onychomycosis.
`
`Acknowledgements -- We wish to thank the medical staff and nursing personnel of the Sint-
`Kamillus Instituut, Bierbeek, Belgium, for their constant and efficient collaboration during this
`clinical study. The technical help that was provided by the research staff of Janssen Pharmaceutica,
`Beerse, Belgium, was deeply appreciated.
`
`mykosen 19, Heft 7 (1976)
`
`5 of 6
`
`

`
`256
`
`j. VANDERDON’CKT, W. LAUWERS and J. BOCKAERT
`
`Literature
`
`1. BOTTEB, A. A., 1971: Topical treatment of
`nail and skin infections with miconazole, a
`new broad spectrum antimycotic. Mykosen
`14, 187--191.
`
`2. HE~NKE, E., 1972: Klinlsche Erfahrungen mit
`Miconazol unter besonderer Ber[icksichtigung
`einer konservativen Behandlung der Onycho-
`mycosen und Peronychien. Mykosen 15, 405
`--407.
`
`3. VAN CUTSEM, J. & D. THIENPONT, 1972:
`Miconazole, a broad-spectrum antimycotic
`agent with antibacterial activity. Chemo-
`therapy 17, 392--404.
`
`4. MULS, M., 1972: A new antifungal agent,
`miconazole nitrate, in the treatment of su-
`perficial mycosis of the glabrous skin. Pro-
`ceedings of the 14th International Congress
`on Dermatology, Padua-Venlce, May 1972.
`5. MANDY, S. H. & T. C. GARRO’rT, 1974: Mi-
`conazole treatment for severe dermatophy-
`toffs. JAMA 230, 72--75.
`6. GAT’tI, F., C. ROSETTI, S. MazlgBO & M.
`LOUTIE, 1973: Traitement des mycoses su-
`perficlelles par le miconazole en milieu tro-
`pical. Presented at the International Sym-
`posium of Medical Mycology, Bucharest, Sep-
`tember 1973.
`
`Author’s address: Dr. J. VANDERDONCKT ~ Medische Dienst -- Psychiatrisch Centrum St. Kamil-
`lus -- 3043 Bierbeek, Belgium.
`
`{ Re~erate
`
`BUTTERFIELD, W. S., S. C. JONG und M. T. ALEXANDER:
`(American Type Culture Collection, Rockville, Md. 20852, USA)
`Aufbewahrung human- und zoopathogener Pilze
`Preservation of living fungi pathogenic for man and animals
`Canadian Journal of Microbiology 20, 1665--1673 (1974)
`Die Arbeit beschreibt die Methoden der ATCC for die Langzeltaufbewahrung patho-
`gener Pilze. Im Vorder~rund stehen die Gefriertro&nung sowie Gefrieren mit nachfol-
`gender Lagerung unter fl0ssigem Stickstoff.
`
`K. LOHRS
`
`LAND, G. A)), W. C. McDONALD2)) R. L. STJERNHOLM und L. FRIEDMAN:
`(Dept. Microbiol. and Immunol., Biol., Biochem., Tulane Univ. Sch, Med., New Orleans,
`Louisiana 70112, USA
`1)Pres. address: Dept. Microbiol., Wadley Inst. Molec Med.,Dallas, Tx. 75235, USA
`2)Pres. address: Dept. Biol., Univ. Texas, Arlington, Texas, 76090, USA)
`Die Filamentation yon Candida alblcans beeinflussenden Faktoren: L)ber Beziehungen
`zwisd~en Aufnahme und Verteilung von Prolin zur Morphogenese
`Factors affecting filamentation in Candida albicans: Relationship of the uptake and
`distribution of proline to morphogenesls
`Infect. Immun. 11, 1014--1023 (1975)
`In Gegenwart verschiedener biologischer Fliissigkeiten (z. B. Serum) in vitro oder in
`Gewebe in vivo konvertiert die Hefe(H)form yon C. aibicans in die filamentiSse Myzei-
`-(M)form. Gewif~ spielen diverse Wirts- und Milieufaktoren eine grofle Rolle dabei sowie
`fi3r die Pathogenese (Lit.Ubers.). W. I. NICKERSON postulierte, dag eine Disulfhydryl-
`reductase diese Moroho~enese konrrolliert durch den enzymatls~en Transfer ,,reduzie-
`render Kratt" von den Mitochondrien zu den Zellw~inden. I’Deshalb Cystein-reiche Me-
`++
`dien). Sp~iter folgten Hinweise auf die Bedeutung yon PhosDhaten, Mg , yore CO2-O:~-
`VerMiltnls, yore S-Adenosylmethionin, yore Biotin usw. Verfasser fanden, daft C. albl-
`cans in phosphatgepuffertem Medium (0,008 M) + Biotin (250 mikrogramm/1) bei hoher
`
`mykosen 19, Hef~ 7 (1976)
`
`6 of 6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket